Clinical Trial Update: A Multicenter, Randomized, Open Label Study to Evaluate the Lipid Lowering Efficacy and Safety of Vytorin® 10/20 vs. Atorvastatin 10mg in Hypercholesterolemia Patients With Metabolic Syndrome in Korea (0653A-129)(COMPLETED) [Phase 3]

View source ↗

Summary

A completed Phase 3 trial comparing Vytorin (simvastatin/ezetimibe) 10/20 mg to atorvastatin 10 mg for lipid lowering in hypercholesterolemia with metabolic syn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Metabolic Syndrome

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2009-11-17